Home › Research › Costs and economics
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life
Yingying Zhu, Natalia Olchanski, Joshua T Cohen, Karen M Freund, Jessica D Faul, Howard M Fillit, Peter J Neumann, Pei-Jung Lin. Journal of Alzheimer's disease : JAD, 2023
Topic: Health services, long-term care and technology
Plain-language summary
Community dwellers with dementia were more likely than those without dementia to receive life-sustaining treatments in their last 90 days of life (advanced dementia: OR = 1.83 [1.42-2.35]; non-advanced dementia: OR = 1.16 [1.01-1.32]). Advance care planning was associated with lower odds of receiving life-sustaining treatments in the community (OR = 0.84 [0.74-0.96]) and in nursing homes (OR = 0.68 [0.53-0.86]). More beneficiaries with advanced dementia received interventions discordant with their EOL treatment preferences. Community dwellers with advanced dementia were more likely to receive life-sustaining treatments at the end of life and such treatments may be discordant with their EOL wishes. Enhancing advance care planning and patient-physician communication may improve EOL care quality for persons with dementia.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Zhu, Y., Olchanski, N., Cohen, J. T., Freund, K. M., Faul, J. D., Fillit, H. M., et al. (2023). Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life. Journal of Alzheimer's disease : JAD. https://doi.org/10.3233/jad-230692
Vancouver
Zhu Y, Olchanski N, Cohen JT, Freund KM, Faul JD, Fillit HM, et al. Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life. Journal of Alzheimer's disease : JAD. 2023. doi:10.3233/jad-230692. PMID: 37955089.
BibTeX
@article{zhu2023-37955089,
author = {Zhu, Yingying and Olchanski, Natalia and Cohen, Joshua T and Freund, Karen M and Faul, Jessica D and Fillit, Howard M and Neumann, Peter J and Lin, Pei-Jung},
title = {{Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life}},
journal = {Journal of Alzheimer's disease : JAD},
year = {2023},
doi = {10.3233/jad-230692},
pmid = {37955089},
url = {https://doi.org/10.3233/jad-230692}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Community dwellers with dementia were more likely than those without dementia to receive life-sustaining treatments in their last 90 days of life (advanced dementia: OR = 1.83 [1.42-2.35]; non-advanced dementia: OR = 1.16 [1.01-1.32]).
- Advance care planning was associated with lower odds of receiving life-sustaining treatments in the community (OR = 0.84 [0.74-0.96]) and in nursing homes (OR = 0.68 [0.53-0.86]).
- More beneficiaries with advanced dementia received interventions discordant with their EOL treatment preferences.
- Community dwellers with advanced dementia were more likely to receive life-sustaining treatments at the end of life and such treatments may be discordant with their EOL wishes.
- Enhancing advance care planning and patient-physician communication may improve EOL care quality for persons with dementia.
New to this subject? Start with our plain-English guide: Costs & economics →
Study details
- Study designcohort study
- Effect sizeOR = 1.83; OR = 1.16; OR = 0.84
- Evidence strengthModerate
How this study scored 63/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 35 of the 56 points we could judge it on, which is 63 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Alzheimer's disease : JAD) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37955089) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 35 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 35 of the 56 points we could judge it on is 63 out of 100. |
| Total | 63 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Costs and economics from nearby years
Also in Costs and economics
21 studies in the library are filed under Costs and economics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Costs and economics hub.